Imaging Sites of Inhibition of Proteolysis in Pathomimetic Human Breast Cancer Cultures by Light-Activated Ruthenium Compound

PLoS ONE - United States
doi 10.1371/journal.pone.0142527
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Inhibition of Cathepsin Activity in a Cell-Based Assay by a Light-Activated Ruthenium Compound

ChemMedChem
Organic ChemistryMolecular MedicinePharmacologyBiochemistryToxicologyDrug DiscoveryPharmaceutics
2014English

Imaging Breast Cancer Chemotherapy Response With Light

Clinical Cancer Research
Cancer ResearchOncology
2010English

Redox Imaging of Human Breast Cancer Core Biopsies

Academic Radiology
Nuclear MedicineRadiologyImaging
2013English

Towards Light Activated Ruthenium‐Arene (RAPTA‐type) Prodrug Candidates

ChemBioChem
Organic ChemistryBiochemistryMolecular MedicineMolecular Biology
2019English

Inhibition of Cell Proliferation by a Resveratrol Analog in Human Pancreatic and Breast Cancer Cells

Experimental and Molecular Medicine
BiochemistryMedicineClinical BiochemistryMolecular BiologyMolecular Medicine
2009English

Differential Regulation of Mitogen-Activated Protein Kinases by Microtubule-Binding Agents in Human Breast Cancer Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
1999English

Breast Cancer Detection by Optomechanical Imaging

2012English

Transient Activation of Dihydropteridine Reductase by Ca2+-Activated Proteolysis.

Zoological Science
Animal ScienceZoology
2000English

Repression of Activated Aryl Hydrocarbon Receptor–Induced Transcriptional Activation by 5α-Dihydrotestosterone in Human Prostate Cancer LNCaP and Human Breast Cancer T47D Cells

Journal of Pharmacological Sciences
Molecular MedicinePharmacology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy